Wiley's Health Care Contracting Chronicles
Pharmacy Benefit Segmentation: Emerging Models for Health Plans
March 18, 2025In this episode of The Wiley Contracting Chronicles, hosts Jordan Ross and Brooke DeLoatch discuss the growing trend of pharmacy benefit segmentation among health plans. They outline three emerging models identified at Wiley: Product Service Disaggregation, Program Segmentation, and Industry Disruption—each offering varying levels of complexity and control. The hosts highlight key considerations for implementing these models, including resource commitment, clear contracting terms, and ensuring service provider capabilities. With careful planning and strategic contract management, health plans can leverage segmentation to foster competition, improve efficiency, and lower drug costs.
Contact Us
For more information, please contact one of the attorneys listed below.
Wiley's Health Care Team
Dorthula H. Powell-Woodson; Brooke M. DeLoatch; Jordan Ross; Lukman Azeez; Kathryn Bucher; Kathleen E. Scott; Tatiana Sainati; Kathleen Cooperstein; Rebecca J. Fiebig; Melany Birdsong; Kelly Baugh; Kirsten C. Hines
 |
 |
 |
Transforming PBM Contracting: The Wiley Approach
December 16, 2024
In this episode of Wiley’s Health Care Contracting Chronicles, hosts Jordan Ross and Brooke DeLoatch share how Wiley’s innovative PBM contracting process helps health plans achieve better pricing, transparency, and efficiency. They outline the five key stages of the Wiley Competitive Contracting process, explain why early legal involvement is a game-changer, and discuss how this method drives meaningful negotiations. Tune in for actionable insights into mastering PBM contracts in a rapidly evolving marketplace.
|
|
|
Understanding Pharmacy Benefit Managers: The PBM Landscape Explained
September 23, 2024In this episode of Wiley’s Health Care Contracting Chronicles, hosts Jordan Ross and Brooke DeLoach introduce the complex world of Pharmacy Benefit Managers (PBMs) and their pivotal role in the healthcare industry. They explore the functions of PBMs as intermediaries between insurers, pharmaceutical companies, and pharmacies, detailing their responsibilities in managing drug benefits and negotiating prices. The discussion also addresses the growing concerns around transparency and regulatory oversight, highlighting recent legislative efforts aimed at reforming PBM practices. Tune in to gain foundational insights into the PBM landscape and what it means for healthcare contracting in the future.
|
|
|
